Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-005387
Filing Date
2024-01-18
Accepted
2024-01-18 16:15:24
Documents
1
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4039
  Complete submission text file 0000950170-24-005387.txt   5615
Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC 200 SMITH STREET WALTHAM MA 02451
Business Address 978-687-6988
Allen Patricia L (Reporting) CIK: 0001348587 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38219 | Film No.: 24541982

Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

EIN.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)